Clinical Trials

50 enrolled

Carcinoma, Neoplasms

NCT07193511 2026-04-16

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

355 enrolled

Neoplasm Metastasis

NCT05376891 2026-04-15

Met Non Small Cell Cancer Registry (MOMENT)

Recruiting

700 enrolled

Neoplasms

NCT06803680 2026-04-15

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

90 enrolled

Neoplasm Metastasis

NCT07005102 2026-04-15

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

854 enrolled

Neoplasms

NCT07532018 2026-04-15

DXP-106

54 enrolled

Neoplasms

NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

681 enrolled

Neoplasm Metastasis, Neoplasms

NCT06150157 2026-04-14

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

220 enrolled

Neoplasms

NCT04802759 2026-04-13

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

316 enrolled

Neoplasm Metastasis

NCT05120596 2026-04-13

First in Human Study of T3P-Y058-739 (T3P)

100 enrolled

Neoplasms

NCT05862285 2026-04-13

UmbrellaMAX

Phase 3 Recruiting

100 enrolled

Neoplasms

NCT05968326 2026-04-13

IMCODE003

260 enrolled

Adenocarcinoma

NCT06178614 2026-04-13

A Study of JNJ-87890387 for Advanced Solid Tumors

Neoplasms

NCT06941272 2026-04-13

MK-9999-01C

50 enrolled

Neoplasms

NCT06979596 2026-04-13

OMAHA-015

250 enrolled

Neoplasms

NCT07209111 2026-04-13

KANDLELIT-014

150 enrolled

Neoplasms

NCT07247110 2026-04-13

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

250 enrolled

Neoplasms

NCT07335497 2026-04-13

ASCEND

290 enrolled

Neoplasm Metastasis

NCT06555744 2026-04-09

A Study of ZW191 in Participants With Solid Tumors

145 enrolled

Neoplasms

NCT06593522 2026-04-07

A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

Neoplasms

NCT06997029 2026-04-07

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

234 enrolled

Neoplasms

NCT05781555 2026-04-06

Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors

Phase NA Recruiting

100 enrolled

Neoplasms

NCT07438782 2026-04-06

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

97 enrolled

Neoplasms

NCT07455617 2026-04-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

101 enrolled

Neoplasm Metastasis

NCT07510828 2026-04-06

PRISM-NK

60 enrolled

Neoplasms

NCT06867705 2026-04-03

RC-102

Phase 3 Recruiting

1,458 enrolled

Neoplasms

NCT06901531 2026-04-03

LUCERNA

Phase 3 Recruiting

500 enrolled

Adenocarcinoma, Neoplasms

NCT07276373 2026-04-03

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

50 enrolled

Neoplasms

NCT03899155 2026-04-01

Pan Tumor Rollover Study

1,500 enrolled

Neoplasms

NCT07213817 2026-04-01

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

114 enrolled

Neoplasm Metastasis

NCT07213830 2026-03-31

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

102 enrolled

Neoplasm Metastasis

NCT06884618 2026-03-30

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

345 enrolled

Neoplasms

NCT05999994 2026-03-27

CAMPFIRE

105 enrolled

Neoplasms

NCT05720117 2026-03-20

A Study of PYX-201 in Advanced Solid Tumors

330 enrolled

Neoplasm Metastasis

NCT07403721 2026-03-19

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

464 enrolled

Neoplasm Metastasis

NCT04443088 2026-03-18

KEYNOTE-E12

78 enrolled

Neoplasm Metastasis, Neoplasms

NCT05719558 2026-03-18

A Study of ASP1002 in Adults for Treatment of Solid Tumors

210 enrolled

Neoplasm Metastasis, Neoplasms

NCT07030712 2026-03-16

MK-8294-001

67 enrolled

Neoplasm Metastasis, Neoplasms

NCT05557045 2026-03-12

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

332 enrolled

Neoplasm Metastasis

NCT06902545 2026-03-11

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Recruiting

377 enrolled

Adenocarcinoma, Neoplasms

NCT06564233 2026-03-06

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

Phase NA Recruiting

90 enrolled

Neoplasms

NCT03435796 2026-03-04

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Phase 2/3 Recruiting

1,541 enrolled

Neoplasms

NCT06713369 2026-03-04

AZD5305

8 enrolled

Neoplasm Metastasis, Neoplasms

NCT03391778 2026-03-03

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

250 enrolled

Neoplasms

NCT07046559 2026-03-03

A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants

104 enrolled

Neoplasms

NCT06014658 2026-03-02

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

130 enrolled

Neoplasms

NCT06759649 2026-02-27

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Neoplasms

NCT06521554 2026-02-25

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Neoplasm Metastasis

NCT07156136 2026-02-25

Study of IMC-P115C in Advanced PRAME-Positive Cancers

140 enrolled